Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Drugs Best First Defense Against Heart Disease for Diabetics

Study finds medicines typically do as well as surgery, especially in less severe cases

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Addison's Disease
Alzheimer's Disease
Aneurysms
Angina Pectoris
More...

Related Healthscout Videos
 border=
The Cure Within
DVT: What You Need to Know
Killing Ourselves
Killing Ourselves
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Animation: What is Hypertension?
Coronary Bypass Surgery
More...

Related Drug Information
 border=
Accupril
Actonel
Actos
Altace
More...

Related News Articles
 border=
Making Your Way Through the Fog of Chemotherapy
Health Tip: When Your Blood Clots Excessively
Putting New Medical Guidelines Into Practice Often Difficult
Caring for Diabetic Pets Helps Humans Get Healthier
More...

SUNDAY, June 7 (HealthDay News) -- Drugs should be the first line of treatment for diabetics who are also battling heart disease, a new study finds.

Only if further steps are deemed necessary should invasive interventions such as angioplasty or bypass surgery be added, the experts said.

Text Continues Below



The issue is crucial to millions of Americans, since diabetes is a major risk factor for coronary artery disease and stroke.

But the findings of the study -- to be presented Sunday at the American Diabetes Association annual meeting in New Orleans and released simultaneously online in the New England Journal of Medicine -- may not end the argument over which approach, medicine or surgery, is the best frontline treatment to ward off heart woes.

The trial enlisted almost 2,400 people with type 2 diabetes, the kind that generally develops in adulthood. These patients also had coronary artery blockages. Outcomes for the entire group were tracked for five years after treatment.

All got intensive drug therapy, either with insulin or with drugs such as metformin that increase the body's sensitivity to insulin, while some also had procedures to improve blood flow.

At five years, 87.8 percent of those getting drug therapy alone were still alive, compared to 88.3 percent of those getting drug therapy plus a surgical procedure -- not a significant difference. The incidence of major cardiovascular events such as heart attacks and stroke was also similar, at 75.9 percent in the medical treatment group and 77.2 percent in the drug-plus-procedure group. In the drug-only group, those getting insulin sensitization treatment did slightly better than those who got insulin therapy.

Reacting to the findings, the Society for Cardiovascular Angiography and Interventions issued a statement saying that the trial still "does not answer" the question of whether all diabetic patients with multi-vessel coronary artery disease might be better treated with optimal drug therapy plus angioplasty or bypass.

Page:  1 | 2 | 3 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 6/8/2009

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





SOURCES: Maria Mori Brooks, Ph.D, associate professor, epidemiology, University of Pittsburgh Graduate School of Public Health; Kirk Garratt, M.D., director, interventional cardiovascular research, Lenox Hill Hospital, New York City; William Boden, M.D., professor, medicine and preventive medicine, State University of New York at Buffalo; June 7, 2009, New England Journal of Medicine online; June 7, 2009, presentation, American Diabetes Association annual meeting, New Orleans


About The HealthScout Network Contact Us
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy